Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Lipid-Based Drug Delivery Systems: The Key Ingredient for Future Medicine"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 5007
Special Issue Editors
Interests: lipidic mesophases; liposomes; lipid-based drug delivery systems; new lipidic–depot systems; controlled drug release; active targeting
Special Issues, Collections and Topics in MDPI journals
Interests: lipid self-assembly; soft matter; lipid-based drug delivery systems; stimuli-responsive drug release; synchrotron science; microplastics
2. School of Environmental and Life Sciences, The University of Newcastle, Callaghan, NSW 2308, Australia
Interests: lipid self-assembly; lipid behavior; synthetic lipids; lipid-based drug delivery; ionic liquids
Special Issue Information
Lipid-based matrices are state-of-the-art tools employed to envelop and protect a vast range of therapeutics from degradation and to deliver them safely to the site of action. Due to their unique ability to compartmentalise hydrophilic and hydrophobic components, they have been utilized to achieve targeted and/or controlled drug release. Whilst a plethora of lipidic drug carriers have been reported in the last few decades, with many lipid-based products already on the market or undergoing clinical trials, there is still a pressing need for new formulations tailored to target different sites of action and to incorporated novel drugs. Moreover, several aspects of their in vivo behaviour in the complex biological environment are not fully elucidated. Research into the innovative use of lipidic platforms in pharmaceutics is vital for their application as a mean to modify or control the release of drugs in vitro and in vivo. This Special Issue aims to highlight research on the encapsulation of pharmaceuticals and bio-pharmaceuticals in lipidic systems, their behaviour in biological environments, controlled release kinetics, and organ-specific bioavailability (e.g., through a targeting strategy). Reviews or original articles on these topics are welcome.
We look forward to receiving your contributions.
Dr. Simone Aleandri
Dr. Wye-Khay Fong
Dr. Livia Salvati Manni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lipid nanoparticles
- controlled release
- targeting strategies
- drug delivery